Maxime Duin

Medical Lead Rlt (Oncology) - France @Novartis

Paris, FR

Medical Lead - HQ role - medical affairs department]Theranostic approach in oncology for the diagnosis and the treatment of metastatic prostate cancer with RLI (Imaging) agent 68Ga-PSMA-11 combined with RLT (Therapeutic) agent 177Lu-PSMA-617- Lead for drugs in the pipeline for prostate cancer : Actinium trials (RLT) & small molecules (not RLT)- Member of brand team to establish strategy for each drug and anticipate data gaps to ensure a good access to market - Set up and launch of retrospective trial based on EAP data : liaison with CRO, redaction of the protocol, consulting with multidisciplinary scientific committee- Point of contact for patients\' association and all related activities- Referent for prostate IIT (Investigator Initiated Trials)- Lead for data generation / RWE projectsMiscalleneous - National (CFU, JFMN, GETUG, FOCUS, JOUM) and international (ASCO GU, ASCO, ESMO, EANM, EAU) congresses- Management of budget - National boards & symposia- Strategy, feasibility and follow up of RLT clinical trials conducted in France- Accountable for performing annual evaluation of sales team on SmPC

University of Montpellier

Master 2 (M2) Ingénierie de la santé, Management / Coordination de Projets en Santé

Université de Poitiers

Docteur en Pharmacie (Pharm. D.), Parcours Industrie

Lycée Paul Guérin de Niort

Baccalauréat Scientifique, Spécialité SVT

Université de Poitiers

Master 1, Recherche et Ingénierie en Bio-santé